… stage I non–small cell lung cancer (NSCLC). Radiation therapy, stereotactic body radiation
therapy (SBRT) in particular, is recommended for those who are not medically fit for surgery.1 …

… Sensitivity analyses of survival after surgery and stereotactic body radiation therapy (SBRT)
for operable early-stage non-small cell lung cancer in selected subgroups. The propensity-…

… Surgical resection has traditionally been considered the standard of care … stage I non-small
cell lung cancer (NSCLC). With the introduction of stereotactic radiation body therapy (SBRT), …

… Stereotactic body radiation therapy is the preferred treatment modality for patients with
inoperable early-stage non–small cell lung … stereotactic body radiation therapy and surgery for …

… , no published randomized trials have shown stereotactic body radiation therapy (SBRT)
to … fractionated radiation therapy (CFRT) for early-stage non-small cell lung cancer (NSCLC). …

… surgical resection for early-stage NSCLC. Many retrospective analyses compared the efficacy
of stereotactic body radiotherapy (SBRT) with surgery … efficacy between SBRT and surgery. …

… treatments. This study compared outcomes between wedge resection and stereotactic body
radiotherapy. … We compared stereotactic body radiotherapy and wedge resection for patients …

… -intent surgery with regional lymph node examination of various extents compare with
long-term survival after stereotactic body radiotherapy for early-stage non–small cell lung cancer? …

… standard treatment for stage I non-small cell lung cancer (NSCLC) is surgery [1]. Lobectomy
with hilar and mediastinal lymph node dissection is preferred given the results of the Lung …

… We aimed to report trends in stereotactic body radiation therapy (SBRT) utilization, dose
prescriptions, and chemotherapy administration for stage I small cell lung cancer (SCLC) in the …